rTMS for Neuroenhancement

Exclusion Criteria

• •Subject satisfies any one or more of the contraindications for TMS Therapy per current treatment guidelines as determined by the PI.
• •History of head trauma associated with loss of consciousness or diagnosed as concussion.
• •History of fainting, syncope, hearing problems or ringing in the ears (tinnitus)
• •Has any metallic implant(s) in or near the head (e.g., pacemaker, defibrillator, neurostimulator, etc.) including any splinters, fragments, clips, etc.
• •Has an implanted stimulator device (including device leads) in or near the head.
• •(e.g. deep brain stimulator, cochlear implant, vagus nerve stimulator.)
• •Has medication infusion device.
• •Subjects with any prior TMS or MRI complications which, in the opinion of the investigator, might interfere with safety, study participation, or which might confound data interpretation,
• •Current diagnosis of a Substance Use Disorder (Abuse or Dependence, as defined by DSM-IV-TR), with the exception of nicotine dependence.
• •Current diagnosis or known history of neurologic or neuropsychiatric disease (e.g., epilepsy, convulsion, seizure)
• •Has a clinically significant abnormality on the screening examination that might affect safety, study participation, or confound interpretation of study results.
• •Participation in any clinical trial with an investigational drug or device within the past month or concurrent with study participation.